Authors of a newly published study on the use of an antidepressant for COVID-19 claim the drug greatly reduces hospitalizations and mortality. But some experts question whether that’s really what the data show.
It’s unclear whether differing odds of dying between men and women reflect inherent differences between male and female immune systems or differences rooted in gender norms.
The CDC now suggests that only children who were within 3 feet, not 6 feet, of an infected student should quarantine, provided they were masked in a classroom. Does the science support this change?
In this webinar brought to you by Bio-Rad, Jörg Bantin and Eddy van Collenburg will discuss when ddPCR should be used instead of qPCR and how to ease the transition.
Can you think of a 5-letter word for “worry of stratospheric proportions”?
Thanks for reading! I’m Christie, and I curate and edit this newsletter. My inbox is always open, so if you have thoughts or ideas about this newsletter or tips for our news team, I’d love to hear from you.
Never miss an email from The Scientist. Click hereto add The Scientist to your safe-sender list.
The Scientist,1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll-Free: (888) 781-0328 | Phone: (705) 528-6888 Email: privacy@the-scientist.com
.png?upscale=true&width=600&upscale=true&name=MSIG-Cast%20Fast-%20Turbomix%20Bis-Tris%20Gel%20Casting%20Kits-%20Learn%20How%20(Banner).png)
%20nov%204.jpg?upscale=true&width=320&height=320&upscale=true&name=800x800%20(1)%20nov%204.jpg "Thinking Digital: When qPCR Doesn’t Make the Cut")
